Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships

Fueled by support from the National Cancer Institute’s “Cancer Moonshot” program, the past few years have witnessed a renewed interest in the canine spontaneous cancer model as an invaluable resource in translational oncology research. Increasingly, there is awareness that pet dogs with cancer provi...

Full description

Bibliographic Details
Main Authors: Marika Klosowski, Laurel Haines, Lauren Alfino, Alexandra McMellen, Michael Leibowitz, Daniel Regan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1130215/full
_version_ 1797862116225449984
author Marika Klosowski
Marika Klosowski
Laurel Haines
Laurel Haines
Lauren Alfino
Lauren Alfino
Alexandra McMellen
Michael Leibowitz
Daniel Regan
Daniel Regan
author_facet Marika Klosowski
Marika Klosowski
Laurel Haines
Laurel Haines
Lauren Alfino
Lauren Alfino
Alexandra McMellen
Michael Leibowitz
Daniel Regan
Daniel Regan
author_sort Marika Klosowski
collection DOAJ
description Fueled by support from the National Cancer Institute’s “Cancer Moonshot” program, the past few years have witnessed a renewed interest in the canine spontaneous cancer model as an invaluable resource in translational oncology research. Increasingly, there is awareness that pet dogs with cancer provide an accessible bridge to improving the efficiency of cancer drug discovery and clinical therapeutic development. Canine tumors share many biological, genetic, and histologic features with their human tumor counterparts, and most importantly, retain the complexities of naturally occurring drug resistance, metastasis, and tumor-host immune interactions, all of which are difficult to recapitulate in induced or genetically engineered murine tumor models. The utility of canine models has been particularly apparent in sarcoma research, where the increased incidence of sarcomas in dogs as compared to people has facilitated comparative research resulting in treatment advances benefitting both species. Although there is an increasing awareness of the advantages in using spontaneous canine sarcoma models for research, these models remain underutilized, in part due to a lack of more permanent institutional and cross-institutional infrastructure to support partnerships between veterinary and human clinician-scientists. In this review, we provide an updated overview of historical and current applications of spontaneously occurring canine tumor models in sarcoma research, with particular attention to knowledge gaps, limitations, and growth opportunities within these applications. Furthermore, we propose considerations for working within existing veterinary translational and comparative oncology research infrastructures to maximize the benefit of partnerships between veterinary and human biomedical researchers within and across institutions to improve the utility and application of spontaneous canine sarcomas in translational oncology research.
first_indexed 2024-04-09T22:14:10Z
format Article
id doaj.art-8e41e7f8ba7e4fa2ae98d75a93cb3b55
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-09T22:14:10Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-8e41e7f8ba7e4fa2ae98d75a93cb3b552023-03-23T05:13:00ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-03-011310.3389/fonc.2023.11302151130215Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnershipsMarika Klosowski0Marika Klosowski1Laurel Haines2Laurel Haines3Lauren Alfino4Lauren Alfino5Alexandra McMellen6Michael Leibowitz7Daniel Regan8Daniel Regan9Flint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesDepartment of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesFlint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesDepartment of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesFlint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesDepartment of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesCenter for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO, United StatesCenter for Cancer and Blood Disorders, Children’s Hospital Colorado, Aurora, CO, United StatesFlint Animal Cancer Center, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesDepartment of Microbiology, Immunology, and Pathology, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United StatesFueled by support from the National Cancer Institute’s “Cancer Moonshot” program, the past few years have witnessed a renewed interest in the canine spontaneous cancer model as an invaluable resource in translational oncology research. Increasingly, there is awareness that pet dogs with cancer provide an accessible bridge to improving the efficiency of cancer drug discovery and clinical therapeutic development. Canine tumors share many biological, genetic, and histologic features with their human tumor counterparts, and most importantly, retain the complexities of naturally occurring drug resistance, metastasis, and tumor-host immune interactions, all of which are difficult to recapitulate in induced or genetically engineered murine tumor models. The utility of canine models has been particularly apparent in sarcoma research, where the increased incidence of sarcomas in dogs as compared to people has facilitated comparative research resulting in treatment advances benefitting both species. Although there is an increasing awareness of the advantages in using spontaneous canine sarcoma models for research, these models remain underutilized, in part due to a lack of more permanent institutional and cross-institutional infrastructure to support partnerships between veterinary and human clinician-scientists. In this review, we provide an updated overview of historical and current applications of spontaneously occurring canine tumor models in sarcoma research, with particular attention to knowledge gaps, limitations, and growth opportunities within these applications. Furthermore, we propose considerations for working within existing veterinary translational and comparative oncology research infrastructures to maximize the benefit of partnerships between veterinary and human biomedical researchers within and across institutions to improve the utility and application of spontaneous canine sarcomas in translational oncology research.https://www.frontiersin.org/articles/10.3389/fonc.2023.1130215/fullcanine (dog)sarcomaosteosarcomacomparative oncologyimmunotherapy
spellingShingle Marika Klosowski
Marika Klosowski
Laurel Haines
Laurel Haines
Lauren Alfino
Lauren Alfino
Alexandra McMellen
Michael Leibowitz
Daniel Regan
Daniel Regan
Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
Frontiers in Oncology
canine (dog)
sarcoma
osteosarcoma
comparative oncology
immunotherapy
title Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
title_full Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
title_fullStr Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
title_full_unstemmed Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
title_short Naturally occurring canine sarcomas: Bridging the gap from mouse models to human patients through cross-disciplinary research partnerships
title_sort naturally occurring canine sarcomas bridging the gap from mouse models to human patients through cross disciplinary research partnerships
topic canine (dog)
sarcoma
osteosarcoma
comparative oncology
immunotherapy
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1130215/full
work_keys_str_mv AT marikaklosowski naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT marikaklosowski naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT laurelhaines naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT laurelhaines naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT laurenalfino naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT laurenalfino naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT alexandramcmellen naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT michaelleibowitz naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT danielregan naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships
AT danielregan naturallyoccurringcaninesarcomasbridgingthegapfrommousemodelstohumanpatientsthroughcrossdisciplinaryresearchpartnerships